Project Grant R21AI193374
Award Date
7/23/25
Completion Date
6/30/27
Dollars Obligated
$445K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Washington, USA
Similar Awards
This federal Project Grant award, valued at $472,210.00 and effective June 23, 2025 through May 31, 2027, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research by the University of Massachusetts Medical School to investigate the spatiotemporal relationship between CD4+ T resident memory cells and neutrophil recruitment in the lungs during pneumonia in experienced...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $479,249 to Washington University to conduct research on the molecular mechanisms regulating neutrophil proinflammatory activity in sepsis. The research aims to understand how neutrophil A20 signaling contributes to organ damage in sepsis, utilizing biochemical, cell biological, and intravital imaging...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $450,630 to Tufts University School of Medicine to conduct research on the interactions between the bacterial pathogen Streptococcus pneumoniae, pulmonary epithelial cells, and neutrophils that contribute to age-associated susceptibility to pneumococcal disease. The objectives are to utilize advanced microscopy...
This Project Grant award, identified as R56AI179656, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA Program 93.855 - Allergy and Infectious Diseases Research. The $350,000 award, effective from Sep 1, 2024 to Aug 31, 2026, supports research by the University of California, Davis to precisely determine the role of vagal afferent neurons, neuro-immune circuitry, and signaling mechanisms in regulating lung inflammation caused by viral pathogens. The...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $831,755 over 5 years to New York University (NYU) to conduct research on the role of lung-resident macrophage subsets in regulating type 2 immune responses and trained immunity. The research aims to elucidate the distinct functions of different macrophage populations, particularly nerve- and...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $639,740.00 to investigate the role of the CD38 enzyme in the development of chronic lung conditions following viral infections like COVID-19. The research aims to explore how targeting CD38 on CD8 tissue resident memory (TRM) cells could mitigate age-associated lung fibrosis after viral pneumonia. The award, effective December 15, 2024 through November 30, 2029, will support the lead researcher...
This $415,250 federal Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research conducted by the University of Rochester to investigate the role of a novel myeloid cell type, long-lived highly differentiated monocyte-derived cells (LDMs), in regulating lung-resident memory T cell (Trm) responses to recurrent influenza virus infection. The key objectives are to determine...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $2,205,213 Project Grant under the Allergy and Infectious Diseases Research (CFDA 93.855) program to the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. The grant, titled "Deciphering Immunopathogenesis of Mucormycosis to Advance Risk Stratification, Diagnosis and Management of the Disease", aims to improve understanding of the immune response and pathogenesis of mucormycosis, a...
This Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to elucidate the mechanisms by which influenza infection can protect against malaria-associated respiratory distress syndrome (MA-ARDS) in mice. The $224,070 award to the University of Utah aims to determine how influenza modifies pulmonary vascular endothelial cells and induces arginase 1-producing...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $402,731 Project Grant under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855) to the University of Washington. The objective of this R38 grant is to increase the number of next generation physician-scientists who can apply knowledge of microbiology, immunology, and research techniques to improve reproductive, maternal, and child health. The grant will support 4 physician-scientists in...